Structure-function analysis of porcine cytochrome P450 3A29 in the hydroxylation of T-2 toxin as revealed by docking and mutagenesis studies.
Guyue Cheng, Changcun Liu, Xu Wang, Hongmin Ma, Yuanhu Pan, Lingli Huang, Haihong Hao, Menghong Dai, Zonghui Yuan
Index: PLoS ONE 9(9) , e106769, (2014)
Full Text: HTML
Abstract
T-2 toxin, one of the type A trichothecenes, presents a potential hazard to human and animal health. Our previous work demonstrated that porcine cytochrome P450 3A29 (CYP3A29) played an important role in the hydroxylation of T-2 toxin. To identify amino acids involved in this metabolic process, T-2 toxin was docked into a homology model of CYP3A29 based on a crystal structure of CYP3A4 using AutoDock 4.0. Nine residues of CYP3A29, Arg105, Arg106, Phe108, Ser119, Lys212, Phe213, Phe215, Arg372 and Glu374, which were found within 5 Å around T-2 toxin were subjected to site-directed mutagenesis. In the oxidation of nifedipine, the CLint value of R106A was increased by nearly two-folds compared with the wild-type CYP3A29, while the substrate affinities and CLint values of S119A and K212A were significantly reduced. In the hydroxylation of T-2 toxin, the generation of 3'-OH-T-2 by R105A, S119A and K212A was significantly less than that by the wild-type, whereas R106A slightly increased the generation of 3'-OH-T-2. These results were further confirmed by isothermal titration calorimetry analysis, suggesting that these four residues are important in the hydroxylation of T-2 toxin and Arg105 may be a specific recognition site for the toxin. Our study suggests a possible structure-function relationship of CYP3A29 in the hydroxylation of T-2 toxin, providing with new insights into the mechanism of CYP3A enzymes in the biotransformation of T-2 toxin.
Related Compounds
Related Articles:
2003-04-01
[Mol. Pharmacol. 63(4) , 784-90, (2003)]
2014-01-01
[PLoS ONE 9(4) , e94885, (2014)]
Interactions of endosulfan and methoxychlor involving CYP3A4 and CYP2B6 in human HepaRG cells.
2014-08-01
[Drug Metab. Dispos. 42(8) , 1235-40, (2014)]
Delamanid does not inhibit or induce cytochrome p450 enzymes in vitro.
2014-01-01
[Biol. Pharm. Bull. 37(11) , 1727-35, (2014)]
2014-11-01
[J. Pharm. Pharmacol. 66(11) , 1623-30, (2014)]